News - MedTech & Diagnostics
Bridging the tensions: Surgical robotics, financial crunch and clinical realities

Dr Matthew Kroh, Chief Medical Officer of Surgical Innovations at Medtronic brings a unique, global perspective to surgical robotics that is at the intersection of clinical practice and medtech leadership.
It is from this vantage point that Dr Kroh offers a more nuanced view of surgical innovation, one that extends beyond the accelerating capabilities of technology to consider the health systems, “financial crunch” and clinical realities that determine whether innovation translate into meaningful outcomes.
In this Health Industry Hub podcast, Dr Kroh reflects on the trajectory that took him from clinical practice and surgical research into medtech leadership, and on the experiences that have challenged his assumptions over the past year. The conversation explores the forces reshaping the medtech sector, from the tensions that sit between technological advancement and the realities of healthcare delivery.
“There is a disconnect in terms of what we hope to do from a technology standpoint, and what healthcare systems understand they need today and in the future,” Dr Kroh commented.
The conversation turns to the convergence of robotics and AI, including the challenges these technologies are being developed to address, and Medtronic’s role in that changing landscape.
“The pressures for clinicians to perform efficiently, with better outcomes and more responsibilities in an electronic healthcare system, can be overwhelming,” stated Dr Kroh. “How do we make it easier for the clinicians to deliver care more efficiently that isn’t onerous and adding to the work burden they have already?”
The discussion spotlights the clinical applications that are proving particularly compelling, as well as the barriers that continue to shape the adoption of surgical robotics in the US and other major markets including Australia.
As the digital surgery ecosystem continues to evolve, the defining question is shifting from what technology makes possible in the operating room to how quickly healthcare systems can translate that potential into practice.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News - Pharmaceuticals
Inside the tensions shaping PBAC decision
The evolving relationship between sponsors, the Pharmaceutical Benefits Advisory Committee (PBAC) and the health technology assessment (HTA) system came under […]
MoreNews - MedTech & Diagnostics
GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda
GenesisCare and Omico are teaming up to bring precision oncology to more patients facing incurable, advanced or poor prognosis cancers. […]
MoreNews - MedTech & Diagnostics
MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy
The race for six seats on the Medical Technology Association of Australia (MTAA) Board is underway, with 10 candidates nominated […]
MoreNews - Pharmaceuticals
New breast cancer drug fills gap left by Zoladex market withdrawal
From 1 October 2026, Diphereline (triptorelin 3.75mg) will become available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of […]
More